Published in Gene Therapy Weekly, February 18th, 2010
Explaining the rationale for the company's novel approach to targeting microRNA pathways, founder and Chief Scientific Officer Dr. Thorleif Moller...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.